About Guelph General Hospital
Guelph General Hospital is a medical care facility in Guelph, Ontario, Canada. It is a 182-bed facility with a total staff of about 1600. The facility opened as a 12-bed unit on 16 August 1875.
There are 216 beds in Guelph General Hospital.
Clinical Trials at Guelph General Hospital
During the past decade, Guelph General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Guelph General Hospital"
#1 collaborator was "Bausch Health, Canada Inc." with 2 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator, "Canadian Critical Care Trials Group" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Guelph General Hospital
According to Clinical.Site data, the most researched conditions in "Guelph General Hospital" are
"Obesity" (2 trials), "Critical Illness" (1 trials), "Deep Venous Thrombosis" (1 trials), "Prostate Cancer" (1 trials) and "Respiration, Artificial" (1 trials). Many other conditions were trialed in "Guelph General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Guelph General Hospital
Most popular intervention types in "Guelph General Hospital" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Contrave 8Mg-90Mg Extended-Release Tablet" (2 trials), "ABR-215050, tasquinimod" (1 trials), "Evidence based weaning protocol" (1 trials) and "LMWH (Fragmin, dalteparin)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Guelph General Hospital
The vast majority of trials in "Guelph General Hospital" are
4 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Guelph General Hospital
Currently, there are NaN active trials in "Guelph General Hospital".
1 are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Guelph General Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Guelph General Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".